Nerve growth factor accelerates wound healing in diabetic mice

Wound Repair and Regeneration

Volumn 12, Issue 1, 2004, Pages 44-52

  Muangman, Pornprom ^a   Muffley, Lara A ^a   Anthony, Joanne P ^a   Spenny, Michelle L ^a   Underwood, Robert A ^b   Olerud, John E ^b   Gibran, Nicole S ^a,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DOSE RESPONSE; EPITHELIZATION; HISTOPATHOLOGY; INFLAMMATION; MALE; MOUSE; NERVE REGENERATION; NONHUMAN; PRIORITY JOURNAL; PUNCH BIOPSY; SKIN NERVE; WOUND; WOUND CLOSURE; WOUND HEALING;

EID: 1342345360     PISSN: 10671927     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1067-1927.2004.012110.x-1     Document Type: Article

References (48)

1. Reiber GE, Pecoraro RE, Koepsell TD. Risk factors for amputation in patients with diabetes mellitus. A case-control study. Ann Intern Med 1992;117:97-105.
2. McNeely MJ, Boyko EJ, Ahroni JH, Stensel VL, Reiber GE, Smith DG, Pecoraro RE. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. How great are the risks? Diabetes Care 1995;18:216-9.
3. Reiber GE, Vileikyte L, Boyko EJ, del Aguila M, Smith DG, Lavery LA, Boulton AJ. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999;22:157-62.
4. Payan DG, Goetzl EJ. Substance P receptor-dependent responses of leukocytes in pulmonary inflammation. Am Rev Respir Dis 1987;136 (6 Part 2):S39-43.
5. Payan DG, McGillis JP, Renold FK, Mitsuhashi M, Goetzl EJ. Neuropeptide modulation of leukocyte function. Ann N Y Acad Sci 1987;496:182-91.
6. Ansel JC, Brown JR, Payan DG, Brown MA. Substance P selectively activates TNF-alpha gene expression in murine mast cells. J Immunol 1993;150:4478-85.
7. Quinlan KL, Song IS, Bunnett NW, Letran E, Steinhoff M, Harten B, Olerud JE, Armstrong CA, Wright Caughman S, Ansel JC. Neuropeptide regulation of human dermal microvascular endothelial cell ICAM-1 expression and function. Am J Physiol 1998;275 (6 Part 1):C1580-90.
8. Gibran NS, Jang YC, Isik FF, Greenhalgh DG, Muffley LA, Underwood RA, Usui ML, Larsen J, Smith DG, Bunnett N, Ansel JC, Olerud JE. Diminished neuropeptide levels contribute to the impaired cutaneous healing response associated with diabetes mellitus. J Surg Res 2002;108:122-8.
9. Gee AP, Boyle MD, Munger KL, Lawman MJ, Young M. Nerve growth factor: stimulation of polymorphonuclear leukocyte chemotaxis in vitro. Proc Natl Acad Sci USA 1983;80:7215-8.
10. Bax B, Blundell TL, Murray-Rust J, McDonald NQ. Structure of mouse 7S NGF: a complex of nerve growth factor with four binding proteins. Structure 1997;5:1275-85.
11. Kennedy WR, Wendelschafer-Crabb G, Johnson T. Quantitation of epidermal nerves in diabetic neuropathy. Neurology 1996;47:1042-8.
12. Dunnick C, Gibran N, Heimbach DM. Substance P has a role in neurogenic mediation of burn wound healing. J Burn Care Rehab 1996;17:390-6.
13. Thompson RJ, Doran JF, Jackson P, Dhillon AP, Rode J. PGP 9.5 - a new marker for vertebrate neurons and neuroendocrine cells. Brain Res 1983;278 (1-2):224-8.
14. Pechan PA, Yoshida T, Panahian N, Moskowitz MA, Breakefield XO. Genetically modified fibroblasts producing NGF protect hippocampal neurons after ischemia in the rat. Neuroreport 1995;6:669-72.
15. Singh N, Birdi TJ, Antia NH. Nerve growth factor production and expression of p75 by Schwann cells and neurofibroblasts in response to M. leprae infection and macrophage secretory products. Neuropathol Appl Neurobiol 1997;23:59-67.
16. Tron VA, Coughlin MD, Jang DE, Stanisz J, Sauder DN. Expression and modulation of nerve growth factor in murine keratinocytes (PAM 212). J Clin Invest 1990;85:1085-9.
17. Gibran NS, Tamura R, Tsou R, Isik FF. Human dermal microvascular endothelial cells produce nerve growth factor: implications for wound repair. Shock 2003;19:127-30.
18. Leon A, Buriani A, Dal T-R, Fabris M, Romanello S, Aloe L, Levi-Montalcini R. Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci USA 1994;91:3739-43.
19. Ehrhard PB, Erb P, Graumann U, Otten U. Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T-cell clones. Proc Natl Acad Sci USA 1993;90:10984-8.
20. Anand P, Terenghi G, Warner G, Kopelman P, Williams-Chestnut RE, Sinicropi DV. The role of endogenous nerve growth factor in human diabetic neuropathy. Nat Med 1996;2:703-7.
21. Kasayama S, Oka T. Impaired production of nerve growth factor in the submandibular gland of diabetic mice. Am J Physiol 1989;257 (3 Part 1):E400-4.
22. Ordonez G, Fernandez A, Perez R, Sotelo J. Low contents of nerve growth factor in serum and submaxillary gland of diabetic mice. A possible etiological element of diabetic neuropathy. J Neurol Sci 1994;121:163-6.
23. Faradji V, Sotelo J. Low serum levels of nerve growth factor in diabetic neuropathy. Acta Neurol Scand 1990;81:402-6.
24. Anand P. Neurotrophins and peripheral neuropathy. Phil Trans Roy Soc Lond B-Biol Sci 1996;351:449-54.
25. Matsuda H, Koyama H, Sato H, Sawada J, Itakura A, Tanaka A, Matsumoto M, Konno K, Ushio H, Matsuda K. Role of nerve growth factor in cutaneous wound healing: accelerating effects in normal and healing impaired diabetic mice. J Exp Med 1998;187:297-306.
26. Spenny ML, Muangman P, Sullivan SR, Bunnett NW, Ansel JC, Olerud JE, Gibran NS. Neutral endopeptidase inhibition in diabetic wound repair. Wound Rep Reg 2002;10:295-301.
27. Greenhalgh DG, Sprugel KH, Murray MJ, Ross R. PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am J Pathol 1990;136:1235-46.
28. Underwood RA, Gibran NS, Muffley LA, Usui ML, Olerud JE. Color subtractive-computer-assisted image analysis for quantification of cutaneous nerves in a diabetic mouse model. J Histochem Cytochem 2001;49:1285-91.
29. Thoenen H, Zafra F, Hengerer B, Lindholm D. The synthesis of nerve growth factor and brain-derived neurotrophic factor in hippocampal and cortical neurons is regulated by specific transmitter systems. Ann N Y Acad Sci 1991;640:86-90.
30. Tuttle JB, Creedon DJ. Pharmacology of nerve growth factor output by target cells. Ann N Y Acad Sci 1993;692:273-6.
31. Nithya M, Suguna L, Rose C. The effect of nerve growth factor on the early responses during the process of wound healing. Biochim Biophys Acta 2003;1620 (1-3):25-31.
32. Murase K, Takeuchi R, Iwata E, Furukawa Y, Furukawa S, Hayashi K. Developmental changes in nerve growth factor level in rat serum. J Neurosci Res 1992;33:282-8.
33. Orenstein NS, Dvorak HF, Blanchard MH, Young M. Nerve growth factor: a protease that can activate plasminogen. Proc Natl Acad Sci USA 1978;75:5497-500.
34. Greene LA, Shooter EM, Varon S. Enzymatic activities of mouse nerve growth factor and its subunits. Proc Natl Acad Sci USA 1968;60:1383-8.
35. Isackson PJ, Dunbar JC, Bradshaw RA. Role of glandular kallikreins as growth factor processing enzymes: structural and evolutionary considerations. J Cell Biochem 1987;33:65-75.
36. Fahnestock M. Structure and biosynthesis of nerve growth factor. Curr Top Microbiol Immunol 1991;165:1-26.
37. Sima AA, Robertson DM. Peripheral neuropathy in mutant diabetic mouse [C57BL/Ks (db/db)]. Acta Neuropathol (Berl) 1978;41:85-9.
38. Fahey TJ 3rd, Sadaty A, Jones WG 2nd, Barber A, Smoller B, Shires GT. Diabetes impairs the late inflammatory response to wound healing. J Surg Res 1991;50:308-13.
39. Li AK, Koroly MJ, Schattenkerk ME, Malt RA, Young M. Nerve growth factor: acceleration of the rate of wound healing in mice. Proc Natl Acad Sci USA 1980;77:4379-81.
40. Paus R, Luftl M, Czarnetzki BM. Nerve growth factor modulates keratinocyte proliferation in murine skin organ culture. Br J Dermatol 1994;130:174-80.
41. Di Marco E, Marchisio PC, Bondanza S, Franzi AT, De Cancedda R, LM. Growth regulated synthesis and secretion of biologically active nerve growth factor by human keratinocytes. J Biol Chem 1991;266:21718-22.
42. Levi-Montalcini R, Dal Toso R. della Valle F, Skaper SD, Leon A. Update of the NGF saga. J Neurol Sci 1995;130:119-27.
43. Olerud JE, Odland GF, Burgess EM, Wyss CR, Fisher LD, Matsen FA3rd. A model for the study of wounds in normal elderly adults and patients with peripheral vascular disease or diabetes mellitus. J Surg Res 1995;59:349-60.
44. Oorschot DE, Jones DG. Neuronal survival and neurite growth in cultured cerebral explants: assessment of the effect of cytosine arabinoside using improved stereology. Brain Res 1991;546:146-50.
45. Schmidt Y, Unger JW, Bartke I, Reiter R. Effect of nerve growth factor on peptide neurons in dorsal root ganglia after taxol or cisplatin treatment and in diabetic (db/db) mice. Exp Neurol 1995;132:16-23.
46. Reynolds ML, Fitzgerald M. Long-term sensory hyperinnervation following neonatal skin wounds. J Comp Neurol 1995;358:487-98.
47. McCarthy BG, Hsieh ST, Stocks A, Hauer P, Macko C, Comblath DR, Griffin JW, McArthur JC. Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology 1995;45:1848-55.
48. Olerud JE, Chiu DS, Usui ML, Gibran NS, Ansel JC. Protein gene product 9.5 is expressed by fibroblasts in human cutaneous wounds. J Invest Dermatol 1998;111:565-72.